Novel Bronchoscopy Method for Molecular Profiling of Lung Cancer: Targeted Washing Technique
10.4143/crt.2024.1128
- Author:
Mi-Hyun KIM
;
Hayoung SEONG
;
Hyojin JANG
;
Saerom KIM
;
Wanho YOO
;
Soo Han KIM
;
Jeongha MOK
;
Kwangha LEE
;
Ki Uk KIM
;
Min Ki LEE
;
Jung Seop EOM
- Publication Type:Original Article
- From:Cancer Research and Treatment
2026;58(1):107-114
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:There have been efforts to find alternative samples other than standard samples of tissue or plasma for mutational analyses for lung cancer patients. However, no other sample or technique has replaced the mutational analyses using standard samples. In this prospective study, we assessed a novel bronchoscopy method, named as targeted washing technique, for detecting the epidermal growth factor receptor (EGFR) mutation.
Materials and Methods:A 3.0-mm ultrathin bronchoscope was precisely navigated to the target lung lesion with the assistance of virtual bronchoscopic navigation and fluoroscopy. Once the bronchoscope is placed in front of target lung lesion, 0.9% normal saline was instilled for targeted washing. EGFR testing using targeted washing fluid (TWF) was compared to standard methods using plasma or tumor tissue.
Results:In 41 TWF samples, the T790M mutation was detected in tissue, plasma, and TWF samples at rates of 22.0%, 9.8%, and 29.3%, respectively. The overall EGFR T790M detection rate using tissue, plasma, or TWF samples was 36.6%, with TWF samples increasing the T790M mutation detection rate by up to 10%. The accuracy of T790M mutation detection using TWF sample was 82.9% compared with standard samples. Four patients were found to have the EGFR T790M mutation solely through EGFR testing using TWF, which repeated rebiopsies using either plasma or tissue finally confirmed to have the T790M mutation.
Conclusion:We demonstrated the clinical potential of targeted washing technique for molecular testing, which can be a good option to overcome spatial heterogeneity, low sensitivity of plasma sample or technical limitations in collecting tumor tissues.
